U.S. Cyclosporiasis 2026: 86% Implied Above 2500 — Live Market

Cyclosporiasis is a parasitic infection transmitted through contaminated food and water, particularly associated with fresh produce like lettuce and berries. The disease is seasonal in the U.S., with cases typically peaking during warmer months (May through August). The CDC actively monitors and reports cyclosporiasis cases through its surveillance system, making the final count verifiable by the market resolution date of July 31, 2026. The current market price of 86% implies traders believe there is a high probability the U.S. will report at least 2500 cases by month's end. Historical context shows variability: 2021 saw approximately 2000 cases, while 2022 recorded around 1270. The 2500-case threshold sits between recent annual totals, making it neither unprecedented nor guaranteed. With roughly two weeks remaining until resolution, the high odds suggest recent case counts are tracking toward the target. The relatively high odds also reflect trader conviction that most remaining cases will be reported before the deadline, even though CDC surveillance lags can delay official confirmation.

What factors could move this market?

Cyclosporiasis outbreaks in the United States are driven by a complex interplay of agricultural practices, food distribution networks, and environmental conditions. The parasite (Cyclospora cayetanensis) requires specific moisture and temperature conditions to complete its oocyst maturation outside the human host, making it uniquely seasonal. Unlike bacterial foodborne pathogens, cyclosporiasis cannot be transmitted directly person-to-person, so outbreaks depend entirely on contaminated produce reaching consumers. Major outbreaks have historically been linked to specific suppliers or growing regions, with Central American countries accounting for a significant portion of U.S. fresh fruit imports during the off-season. Several factors support the YES side (≥2500 cases). First, the market is currently priced at 86%, indicating traders perceive robust case accumulation through late July. Cyclosporiasis cases detected by the CDC are cumulative year-to-date, and surveillance systems cast wider nets each season as lab capacity and physician awareness improve. With approximately 16 days remaining until resolution, most cases that will be reported by July 31 are likely already in transit through the surveillance pipeline. Second, 2026 spring and early summer conditions could have favored oocyst survival and produce contamination, particularly if growing regions experienced optimal moisture levels. Third, if a large multistate outbreak occurred in June or early July, case counts would accumulate rapidly. Counterarguments for the NO side (<2500 cases) center on surveillance lag and outbreak containment. Not every infected person seeks medical care or receives a diagnosis, so clinical case counts underestimate true incidence. If most infections remain unreported or unconfirmed by July 31, the official CDC tally could fall short of 2500. Additionally, if produce contamination events were geographically scattered or smaller than historical outbreaks, case accumulation would be slower. Weather-related delays in harvest or transportation might also suppress case detection timing. The 86% odds reflect trader confidence in high official case counts, suggesting either recent data points have already indicated strong accumulation, or market participants anticipate July's remaining period will see significant case reporting. Historical precedent (2021's ~2000 cases) shows the threshold is achievable but not automatic. The gap between 2021 and 2022 underscores how variable annual totals can be. Current odds imply traders are pricing in above-median risk for this particular year, possibly because spring 2026 conditions favored transmission or because outbreak detection has been particularly robust to date.

What are traders watching for?

• July 31, 2026 market deadline: CDC must officially report cumulative case count by this date for resolution.
• CDC surveillance updates: Major case count surges typically occur when regional systems report batch confirmations mid-week.
• Produce contamination investigations: Identification of affected shipment sources and recalls accelerate case detection.
• Multistate outbreak clusters: Large coordinated outbreaks accumulate cases rapidly; scattered incidents grow slower.
• Laboratory capacity and physician awareness: Enhanced testing and clinical vigilance in final two weeks drive case identification.

How does this market resolve?

The market resolves YES if the CDC reports at least 2500 total cyclosporiasis cases in the United States by July 31, 2026; NO if the official count falls below 2500. Resolution depends on CDC's verified surveillance data published by the market end date.